Biotechnology
Pharmaceutical
Health

Flexion Therapeutics

$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.54 (-4.72%) Today
$0.00 (0.00%) As of 4:36 PM EDT after-hours

Why Robinhood?

You can buy or sell FLXN and other stocks, options, ETFs, and crypto commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. Read More It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.

Employees
272
Headquarters
Burlington, Massachusetts
Founded
2007
Market Cap
435.02M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
628.25K
High Today
$11.51
Low Today
$10.90
Open Price
$11.46
Volume
357.72K
52 Week High
$27.84
52 Week Low
$9.65

Collections

Biotechnology
Pharmaceutical
Health
Therapy
Technology
2014 IPO
US
North America

FLXN News

Yahoo FinanceJun 24

Here’s What Hedge Funds Think About Flexion Therapeutics Inc

183
Yahoo FinanceJun 20

Flexion Therapeutics Named one of Boston Business Journal’s Best Places to Work for the Third Consecutive Year

56
Seeking AlphaJun 17

Flexion: Finally Looking For An Entry

160

FLXN Earnings

-$1.43
-$0.75
-$0.06
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

More FLXN News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.